Acceleron Pharma Inc. Stock Price (XLRN)

Key Statistics

Open
Previous Close
Bid
Ask
Day Range -
52 Week Range -
Volume
Avg. Volume
Volume to USD
Market Cap
Beta
PE Ratio
Latest EPS
EPS TTM
Dividend
Dividend Yield
Ex-Dividend Date
Revenue TTM
Revenue per Share
Revenue per Employee
Profit Margin
Gross Profit TTM
Total Cash TTM
Total Debt TTM

Share Distribution

Shares Outstanding
Float
Short Interest
Short Ratio
Insider Ownership
Institution Ownership

Latest Headlines

How Tap an ex-US Healthcare BoomFri, 16 Nov 2018 11:40:46 UTC via ETF Trends
Total Pharma Tracker's Daily BioPharma Focus: Questions Surrounding Amarin's Trial DataFri, 16 Nov 2018 10:59:40 UTC via Seeking Alpha
China Pharma Holdings' (CPHI) CEO Zhilin Li on Q3 2018 Results - Earnings Call TranscriptThu, 15 Nov 2018 20:07:10 UTC via Seeking Alpha
Zealand Pharma AS (ZEAL) CEO Britt Meelby Jensen on Q3 2018 Results - Earnings Call TranscriptThu, 15 Nov 2018 15:19:08 UTC via Seeking Alpha
CareTrust: Wait For A Drop Before Buying This 4.2%-Yielding Healthcare REITThu, 15 Nov 2018 07:43:08 UTC via Seeking Alpha
Mallinckrodt Plc (MNK) Presents at Jefferies London Healthcare Broker Conference Call (Transcript)Wed, 14 Nov 2018 23:28:08 UTC via Seeking Alpha
Geron Corporation (GERN) CEO John Scarlett Presents at Stifel 2018 Healthcare Conference Call TranscriptWed, 14 Nov 2018 19:49:15 UTC via Seeking Alpha
Walgreens Boots Alliance's (WBA) CEO Stefano Pessina Credit Suisse Healthcare Conference - TranscriptWed, 14 Nov 2018 18:50:08 UTC via Seeking Alpha
Zosano Pharma (ZSAN) CEO John Walker on Q3 2018 Results - Earnings Call TranscriptWed, 14 Nov 2018 18:34:16 UTC via Seeking Alpha
Bristol-Myers Squibb (BMY) Presents at Credit Suisse Healthcare Conference (Transcript)Wed, 14 Nov 2018 16:25:08 UTC via Seeking Alpha

Acceleron Pharma Inc. Performance

5 Day Change 1 Month Change 30 Day Change 3 Month Change 90 Day Change 6 Month Change 180 Day Change Year to Date Change 1 Year Change 2 Year Change 5 Year Change

Active Alerts for IEX:XLRN

You don't have any alerts set for IEX:XLRN.

About Acceleron Pharma Inc.

Acceleron Pharma Inc is a biotechnology company which focuses on discovery, development, and commercialization of novel therapies. It aims to discover key natural regulators of cellular growth and repair.

CEOHabib J. Dable IndustryBiotechnology SectorHealthcare Websitehttp://www.acceleronpharma.com Issue ExchangeNASDAQ Global Market Issue TypeUnknown

Real-time XLRN to USD Trade Analysis on IEX

Market Status Closed

Analysis is available when the exchange & market are open.